Bioethics of intervention and the case of drugs Bevacizumab and Ranibizumab for retinal diseases. RIB [Internet]. 2016 Oct. 11 [cited 2026 Feb. 5];(2):1-10. Available from: https://revistas.comillas.edu/bioetica-revista-iberoamericana/article/view/7346